Defining Exacerbation Could Produce Endpoint For Non-Cystic Fibrosis Bronchiectasis, FDA Told
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency received input on the natural history of the disease and options for measuring exacerbation to assess therapeutic success during a Sept. 7 workshop.